Clinical trial
A Multi-cEnter, Pilot, Crossover Trial of Prophylactic Wilate coMpared to PlacebO for Heavy Menstrual Bleeding in Patients With Von WillEbRand Disease
NCT06205095 is registered in ClinicalTrials.gov with Unity Health Toronto as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-cEnter, Pilot, Crossover Trial of Prophylactic Wilate coMpared to PlacebO for Heavy Menstrual Bleeding in Patients With Von WillEbRand Disease
- Lead sponsor
- Unity Health Toronto
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- October 21, 2024
- Completion date
- September 30, 2028
- Enrollment
- 20 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.